Figure 3: Schematic representation of the link between TRAIL and resistin/lipocalin-2 (ngal) in the context of obesity-induced metabolic alterations. The picture summarize the hypothesized axis between TRAIL and resistin and lipocalin-2/ngal leading to different outcomes according to TRAIL levels.